ENDPOINTS

Argenx’s Vyvgart Hytrulo syringe is approved in the US; Opthea to cut 65% of staff

Plus, news about Protagonist Therapeutics, Pfizer and Keros Therapeutics: Argenx wins FDA approval for Vyvgart Hytrulo syringe: The subcutaneous injection, which comes in a more convenient prefilled syringe, can be self-administered by the patient. Vyvgart ...

Apr 11, 2025 - 15:08
 0
Argenx’s Vyvgart Hytrulo syringe is approved in the US; Opthea to cut 65% of staff
Plus, news about Protagonist Therapeutics, Pfizer and Keros Therapeutics: Argenx wins FDA approval for Vyvgart Hytrulo syringe: The subcutaneous injection, which comes in a more convenient prefilled syringe, can be self-administered by the patient. Vyvgart ...
Read More

Tags:

Previous Article

She Worked in a Harvard Lab to Reverse Aging, Until ICE Jailed Her

Next Article

Costco and Unilever boost credibility of refillable packaging

Related Posts

Visen Pharmaceuticals prices $86M Hong Kong IPO

Visen Pharmaceuticals prices $86M Hong Kong IPO

Mar 20, 2025  0

Cassava ends work on Alzheimer's drug; Alumis gets $40M upfront from Kaken

Cassava ends work on Alzheimer's drug; Alumis gets $40M...

Mar 25, 2025  0

Judge grants new nationwide block on NIH payment cuts 

Judge grants new nationwide block on NIH payment cuts 

Mar 5, 2025  0